PMDA drug package insert
セイブル錠25mg
PMDA Prescription drug · 株式会社三和化学研究所 · package insert Mar 17, 2026
Key facts
| Brand names | セイブル錠25mg, セイブル錠50mg, セイブル錠75mg |
|---|---|
| Nonproprietary names | ミグリトール |
| Companies | 製造販売元／株式会社三和化学研究所 |
| Product type | Prescription drug |
| Therapeutic category | 糖尿病食後過血糖改善剤 |
| Therapeutic category codes | 873969 |
| YJ codes | 3969009F1023, 3969009F2020, 3969009F3026 |
| Approval numbers | 21700AMY00238000, 21700AMY00239000, 21700AMY00240000 |
| Package insert edition | 第3版 |
| Package insert date | Mar 17, 2026 |
| PMDA document key | 300297_3969009F1023_1 |
| PMDA company code | 300297 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: